With regulations, limited human and financial capital are being wasted on achieving compliance with profit-sapping rules, as opposed to all forms of capital being directed to their highest, most productive, and profitable use.
For one thing, it signals that these companies are finding ways of using these new technologies to make their medicines more effective --making for better odds in getting Food and Drug Administration approval and reducing money wasted testing drugs that won't work in human beings.